ChargePoint Technology Acquires PuroVaso
ChargePoint Technology has acquired single-use container company PuroVaso.
ChargePoint Technology announced on August 25, 2022 that it had acquired PuroVaso, a company focused on the design, development, and manufacture of single-use containers.
According to a company press release, the acquisition is designed to complement ChargePoint’s existing portfolio of containment and sterile transfer technology. When combined with PureVaso’s single-use solutions, ChargePoint believes it can give pharmaceutical manufacturers a broader choice of powder and liquid transfer, storage, and handling products.
"PuroVaso has vast technical expertise in pharmaceutical processing, transfer, handling and storage, with a broad portfolio of products that customers rely on for critical process applications,” said Chris Eccles, CEO of ChargePoint, in a company press release. “With its extensive process knowledge, application engineered solutions, and relentless customer focus, PuroVaso offers leading solutions to highly regulated pharma and biopharma landscapes along with several other process critical markets. We are very excited to have PuroVaso join the ChargePoint portfolio of solutions.”
Source: ChargePoint
New Cancer Research and Treatment Center in Development in London
May 1st 2025Aviva Capital Partners and developer Socius are investing £1 billion in a 12-acre site to be located at the London Cancer Hub next to The Institute of Cancer Research, London and The Royal Marsden NHS Foundation Trust’s Sutton site.
